Publications

Opioid agonist therapy Gap Coverage Program : information for health care providers

Description

Opioid agonist therapy (OAT), which entails the provision of medications like buprenorphine/naloxone or methadone, is an evidence-based treatment option for opioid use disorder. This fact sheet provides information for health care providers about the OAT Gap Coverage Program, which is designed to provide immediate, no-cost access to OAT drugs for patients who do not have supplementary health benefit coverage.

Updated

August 1, 2024

Tags
OAT gap coverage program health benefits opioid opioid agonist therapy

Title and publication information

Type
Fact Sheet
Frequency

Other

Publisher / Creator Information

Creator
Health
Publisher

Health

Place of Publication

Edmonton

Resource Dates

Date Created

2021-12-01

Date Added

2021-12-08T20:23:59.998090

Date Modified

2024-08-01

Date Issued

2021-12-08

Identifiers

Usage / Licence

Contact

Contact Name

Alberta Health

Contact Other

Alberta Health Services Addiction Helpline 1-866-332-2322